Greenwich LifeSciences's total assets for Q3 2024 were $5.83M, a decrease of -19.42% from the previous quarter. GLSI total liabilities were $842.38K for the fiscal quarter, a -37.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.